Laurus Labs announced that it has received the licence from Defence Research & Development Organisation (DRDO) to manufacture and market of 2-Deoxy-D-Glucose (2DG).
2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country.
Laurus Labs has already applied with CDSCO for emergency use authorization (EUA) for 2DG.
Losing weight is a significant milestone, but for many, the bigger battle lies in keeping…
In recent months, a growing controversy has surfaced regarding the presence of heavy metals—specifically lead…
A new study published in Scientific Reports has shed light on the potential benefits of dietary…
Zinc is an essential mineral that plays a crucial role in maintaining overall health. Known…
A groundbreaking clinical trial, spearheaded by a team of Indian and international experts, has shed…
In an unprecedented discovery, scientists have uncovered a surprising connection between COVID-19 infections and the…